Hosted on MSN2mon
Corbus, Viking initiated at overweight by Piper SandlerThe bank noted that Phase 1 testing for CRB-913 was expected to begin in Q1, with data in the second half of 2025. Piper set a price target for Corbus of $35.For Viking (), Piper cited the company ...
NORWOOD, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval ...
NORWOOD, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback